Cardiovascular Diseases Clinical Trials in Kansas City, Kansas

6 studies are recruiting for cardiovascular diseases in Kansas City, Kansas right now. Each one is listed on ClinicalTrials.gov, the public registry the research teams themselves file with. TrialBoost is not a doctor, a research site, or a study sponsor: the research team decides who takes part.

Search these by distance from you

Studies now recruiting

  1. Investigation of the BrioVAD System for the Treatment of Left Ventricular Heart Failure

    The goal of this study is to evaluate the safety and efficacy of the BrioVAD System by demonstrating non-inferiority to the HeartMate 3 Left Ventricular Assist System when used for the treatment of advanced, refractory, left ventricular heart failure.

    Stage
    Not phased
    Ages
    18 to 100
    Site
    The University Of Kansas Medical Center, Kansas City, Kansas
    Locations
    47 in total
    Run by
    BrioHealth Solutions, Inc.

    See if you can join NCT06310031 on ClinicalTrials.gov

  2. A Study of Mosliciguat in Combination With Inhaled Treprostinil in PH-ILD

    This is a Phase 2, open-label, multi-center clinical study to evaluate the safety and tolerability of inhaled mosliciguat in participants with pulmonary hypertension associated with interstitial lung disease (PH-ILD) on a background inhaled treprostinil.

    Stage
    Phase 2
    Ages
    18 to 85
    Site
    Clinical Research Site, Kansas City, Kansas
    Locations
    13 in total
    Run by
    Pulmovant, Inc.

    See if you can join NCT07333183 on ClinicalTrials.gov

  3. Pragmatic Evaluation of Events And Benefits of Lipid-lowering in Older Adults

    PREVENTABLE is a multi-center, randomized, parallel group, placebo-controlled superiority study. Participants will be randomized 1:1 to atorvastatin 40 mg or placebo. This large study conducted in community-dwelling older adults without cardiovascular disease (CVD) or dementia will demonstrate the …

    Stage
    Phase 4
    Ages
    75 and older
    Site
    University of Kansas Medical Center, Kansas City, Kansas
    Locations
    106 in total
    Run by
    Duke University

    See if you can join NCT04262206 on ClinicalTrials.gov

  4. The Oxford Risk Factors And Non-Invasive Imaging Study

    ORFAN is a prospective, multi-centre, multi-ethnic cohort observational study collecting CT scans, biological material and outcomes data, to develop and validate novel biomarkers of cardiometabolic and other disease risk.

    Stage
    Not phased
    Ages
    18 to 99
    Site
    Midwest Heart & Vascular Specialists LLC, Kansas City, Kansas
    Locations
    45 in total
    Run by
    University of Oxford

    See if you can join NCT05169333 on ClinicalTrials.gov

  5. Trial to Evaluate Safety And Effectiveness of Mechanical Circulatory Support in Patients With Advancing Heart Failure

    The purpose of TEAM-HF IDE clinical trial is to evaluate safety and effectiveness of the HeartMate 3 LVAS compared to guideline directed medical therapy (GDMT) in a population of ambulatory advanced heart failure patients who are not dependent on intravenous inotrope.

    Stage
    Not phased
    Ages
    18 and older
    Site
    Kansas University Medical Center, Kansas City, Kansas
    Locations
    68 in total
    Run by
    Abbott Medical Devices

    See if you can join NCT06526195 on ClinicalTrials.gov

  6. Sympathetic-vascular Dysfunction in Obesity and Insulin Resistance (Vitamin C Study)

    The main purpose of research is to examine and understanding the development of hypertension in obese adults with insulin resistance. Findings from our studies will identify unique mechanisms that can be targeted to limit increases in vascular dysfunction and reduce the excessively high prevalence …

    Stage
    Phase 1
    Ages
    35 to 65
    Site
    University of Kansas Medical Center, Kansas City, Kansas
    Run by
    University of Kansas Medical Center

    See if you can join NCT04715022 on ClinicalTrials.gov

How to read this page. Every study here comes from ClinicalTrials.gov, the public registry that research teams are required to file with. We have summarised each one in plain language and shown where it is running. We have not changed what any study says it is doing.

What TrialBoost is. We help people find research that might suit them, and, if they ask us to, we pass their details to the research team running it. We are not a doctor, a research site, or a study sponsor, and we do not decide who takes part in anything. Joining costs nothing and you can change your mind at any point.

Paid placement. Some studies pay us when someone asks to be connected to them. Those are labelled Sponsored wherever they appear, and they only appear when they match what you were actually looking for.